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Abstract 
BACKGROUND: Mental health is a state of well-being in which an individual is able to 
acknowledge ability levels, cope with the normal stresses of life, be a productive member of society 
and contribute to the community.  An important consideration for DNP prepared nurses is 
implementing principles of the Collaborative Care Model as a guiding framework to improve access 
to evidence-based mental health care in a medical care setting.   
 
PURPOSE: The purpose of this DNP project was to examine the demographic, clinical and 
treatment characteristics of patients with both medical and psychiatric diagnoses admitted to an 
Intensive Care Unit (ICU) of a hospital in a large healthcare system located in a metropolitan area 
in the southeast United States.    
 
METHODS: For the study in this DNP project, an exploratory, descriptive design with a 
retrospective medical record review was conducted on 100 patients with both medical and 
psychiatric diagnosis admitted to the ICU between July 1, 2018 and December 31, 2018.  This 
study was an exploration of demographic, clinical and treatment characteristics of patients with 
both a medical and psychiatric diagnosis admitted to the ICU during the study period. The 
relationships among and between the psychiatric medication reconciliation status, type of 
psychiatric treatments received, length of stay and discharge disposition of the study sample were 
explored.  
RESULTS: Those who had psychiatric diagnosis on admission were more likely to be female 
(60.0% vs. 40%), have a neurological condition as the admitting diagnosis (63%) and suffer from 
co-existing medical diagnosis including cardiac/pulmonary (83%).  The nonexclusive, primary 
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psychiatric diagnosis was anxiety (75%), follow by depression (63%) with nearly three quarters of 
the sample on a psychiatric medication prior to admission (71%).  The most common psychiatric 
medication was an antidepressant/mood stabilizer (56%).  There were no significant differences in 
admission diagnosis, co-existing medical diagnosis, restraint use, PRN medication use, psych 
consult, disposition or length of stay between those with and without psychiatric medications on 
admission. 
CONCLUSION: There remains limited research concerning collaborative care in the inpatient 
healthcare setting.  The preliminary findings of this DNP project suggest the need for more 
exploratory research that can guide practice and policies to enhance care for patients with 
psychiatric and medical comorbidities in the ICU setting.    
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An Evaluation of Preexisting Psychiatric Diagnosis: 
 Patient Outcomes in an Intensive Care Setting 
Introduction 
 A mental illness is defined as a change or alteration in a person’s thinking, emotions, 
behavior or a combination of these conditions (American Psychiatric Association (APA), 2018).  
Mental illnesses can range from a phobia or intellectual disability, which does not limit one’s 
functional abilities, to severe depression, schizophrenia, or substance abuse that may compromise 
functioning and require hospitalization. A comorbid mental health condition occurs when an 
individual suffers from co-existing mental and physical health conditions simultaneously.  A recent 
report from the Substance Abuse and Mental Health Services Administration (SAMHSA, 2017b) 
defined comorbid mental and physical illnesses as the presence of two or more diseases that not 
only co-exist but also tend to exacerbate prognosis and precipitate the number and severity of 
complications, thereby compromising efficacy of treatments.    
With the spiraling, unsustainable costs of healthcare today and the focus on reducing 
overall healthcare costs, the cost of treatment for co-existing conditions is also a variable of 
concern.  Yoon and Bernell (2013) reported that adverse mental and physical illness events are 
associated with as much as a threefold increase of clinical office visits and medication treatment.  
For example, in comorbid diabetes and depression, patients are on a downward spiral as poor 
glycemic control can lead to an increase in symptoms of depression, which in turn leads to 
compromises in self-care as well as poor medication adherence and poor dietary regimens and 
glycemic control.  Although integrating the care of mental and physical illnesses reduces the 
overall severity and cost of both conditions (SAMHSA, 2017b), current healthcare practice tends 
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to address and treat these conditions separately.  Increased education about mental illness to 
primary care providers and a care delivery system designed around the efficacy of services using 
a collaborative care model can provide a more integrated health model and lower overall healthcare 
cost (Rolls, Davis, & Coupland, 2002).     
Problem Statement 
 The majority of research to date reports on medical and psychiatric illnesses separately or 
only medications for physical conditions.  Yet, fully integrated care, which provides 
comprehensive care for both medical and psychiatric illnesses, can improve patient outcomes and 
quality of care (Reiss-Brennan, et al., 2016).  The majority of providers in the ICU setting do an 
excellent job of managing patients’ physical needs.  However, patient’s psychiatric needs may be 
unmet, particularly when psychiatric medications are abruptly stopped upon admission to the ICU, 
despite the occurrence of accurate medication reconciliation.  The practice of abrupt 
discontinuation of psychiatric medications can cause an exacerbation of patient’s symptoms and 
possibly result in psychosis (National Institutes of Mental Health, 2010).  These reports support 
the importance of studying the characteristics of patients admitted to the ICU with a psychiatric 
diagnosis and how psychiatric diagnosis influences clinical and treatment use modalities.   
Study Purpose/Aims 
 The purpose of this study was to examine the demographic, clinical and treatment 
characteristics of patients with both medical and psychiatric diagnoses admitted to an Intensive 
Care Unit (ICU) of a hospital in a large healthcare system located in a metropolitan area in the 
southeast United States. 
The specific aims were to: 
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 Conduct a retrospective electronic medical record review to examine the frequency in 
which patients with a psychiatric diagnosis are admitted to the ICU. 
 Examine the frequency in which psychiatric medication reconciliations are completed for 
patients with a psychiatric diagnosis who are admitted to the ICU.  
 Examine the relationship of a prior to admission psychiatric medication use and use of 
recommended treatment modalities, patterns of service use and disposition upon discharge 
from the hospital.   
Theoretical Model 
 The theoretical model chosen to guide this Doctorate of Nursing Practice project was Lydia 
E. Hall’s theory of Core, Care and Cure (1964).  Kimball and colleagues (2017) suggested that 
Hall viewed patients as three overlapping parts; the core (patient’s psyche), the care (intimate care 
of the body) and the cure (the medical aspects of the patient).  Hall described the cure as the 
primary factor considered when a patient entered a hospital in the acute phase of a disease.  
Because of the primary focus, Hall suggested that the hospital environment created a difficult 
psychological experience for the ill individual.  For instance, when the primary focus is on cure, 
all efforts are focused on giving medications or treatments to resolve or improve the pathological 
cause of the disease.  In addition, healthcare providers tend to spend the majority of time working 
towards a medical cure.  However, providers may give little thought to the patient’s psychological 
response to how the disease and treatment.  In contrast, Hall’s Core, Care and Cure Theory expands 
on the curative thinking to include a holistic, collaborative approach of caring for patients suffering 
both medical and mental illnesses to include how the pathology affects the patient’s core.  In sum, 
Hall believed all three parts were equal and required equal attention (Alligood, 2014).   
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Evidence Based Intervention 
 Despite Hall’s theory being developed in the 1960s, multiple collaborative or integrated 
care models have only begun to emerge within the last 10 years in an effort to provide a more 
holistic approach to patient care.  One evidence-based intervention is the Collaborative Care Model 
(CCM) developed by the American Psychiatric Association (APA) and the Academy of 
Psychosomatic Medicine (APM).  The CCM operationalizes the principles necessary to improve 
access to evidence based mental health care in a medical care setting (APA, 2016).  The CCM 
provides an approach for both chronic medical and mental illnesses.  The focus of the CCM is on 
four core elements of integrating mental and primary health care.  The core elements specify that 
care must be: 1) team-driven, 2) population-focused, 3) measurement-guided, and 4) evidence-
based.  Although the CCM was originally designed to be implemented in a primary care setting 
with the primary care physician (PCP) as the team leader, it can be expanded to all patient care 
settings which involve multiple disciplines, including those who are providers in hospital settings.  
 The CCM stresses the need for a team based approach to patient care to include a 
multidisciplinary group of professionals such as: 1) primary care physicians; 2) advanced practice 
registered nurses; 3) case managers; 4) registered nurses; 5) social workers and 6) mental health 
practitioners (APA, 2016).  Typically, the primary care practitioner is the ultimate decision maker 
in the patient’s care yet can readily draw on the expertise of the numerous other professionals of 
the CCM team.  The second core element of the CCM is the basis of population-focused care and 
how the individual affects the overall health of a set population.  In using systematic, disease-
specific, patient-reported outcome measures the CCM is measurement guided and able to track 
individual patient health as well as the overall population health.  Measureable outcome tracking 
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allows for the identification of modifiable outcomes in which evidence-based interventions can be 
implemented to improve the overall individual and population health.  
Literature Review 
Approximately 20% of all adults in the United States will experience a mental illness and 
of those, 9% will have a substance abuse problem (APA, 2018).  In Kentucky alone, the average 
number of mentally unhealthy days was four out of the preceding 30 days studied.  In addition, 
during the year preceding the report, Kentucky’s incidence of adults experiencing a serious mental 
illness was greater than 5%, compared to the average of 4% in the United States (SAMHSA, 
2017a).  Furthermore, more than 40% of all individuals in the United States have a chronic physical 
illness (Centers for Disease Control and Prevention (CDC), (2012).  People with co-existing 
mental and physical health conditions tend to have even higher rates of chronic health conditions 
including hypertension, asthma, diabetes, heart disease and stroke that are often secondary to the 
side effects of psychotropic treatments, disparities in health care access and utilization of services 
(De Hert et al., 2011).   
Mental illness can lead to an impaired ability to engage in adequate self-care of the co-
existing physical illness, thereby contributing to poor health outcomes and an increase in the 
overall health care cost.  Recent reports indicate that individuals who suffer from co-existing 
mental and chronic physical health conditions experienced healthcare costs 75% higher than those 
without a co-occurring mental and physical health illness (SAMHSA, 2017b). Even so, healthcare 
professionals too often make a clear distinction between mental and physical illness when one 
condition should not be addressed to the exclusion of the other.    
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 Comorbid mental and physical illnesses will affect an increasing number of individuals as 
advances in medicine increases the likelihood of a prolonged life without curing diseases, thus 
resulting in two or more co-existing illnesses (World Health Organization (WHO), 2005).  In 
addition, the overall increase in life expectancy, increased risk for late-onset diseases and 
unhealthy life styles may contribute to an increased number of mental and chronic physical 
illnesses in the population (WHO, 2015).  In accordance with the increased number of chronic 
mental and physical illnesses, treatment interventions are likely to result in greater use of 
medications in treatment, especially for those with chronic illnesses.  For example, the increased 
number of medications for chronic illnesses highlights the importance of The Joint Commission 
2019 Hospital National Patient Safety Goal of accurate and complete medication reconciliation 
(The Joint Commission, 2018).   
 Medication reconciliation is the process of generating the most accurate listing of a 
patient’s medications, including the drug name, dosage, frequency and route (Institute for 
Healthcare Improvement, 2019).  The goal of medication reconciliation is for the patient’s 
medication listing to be reviewed at all transition points as the patient transverses the healthcare 
process, in order to assure correct, appropriate continuation of the patient’s medications.  
Discrepancies in medication reconciliation create inadvertent inconsistencies across care and leave 
patients vulnerable to adverse drug events.  Although the inconsistencies typically are 
unintentional, a 2018 study by the Agency for Healthcare Research and Quality (AHRQ) found 
that more than 50% of hospitalized patients’ medication lists contained at least one discrepancy 
and of those, 40% were identified to have the potential to cause harm.   
 Medication reconciliation is especially important for patients admitted to the ICU.  Bell et 
al. (2011) reported an increased risk of discontinuation of medications for physical conditions upon 
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admission to the ICU when compared to patients who are hospitalized but do not have an ICU 
admission.  Despite having a documented preexisting mental illness, greater than 20% of patients 
reported developing depression during an ICU admission (Davydow, Gifford, Desai, Bienvenu & 
Needham, 2009).  Furthermore, approximately 40% of patients admitted to the ICU were 
diagnosed with anxiety following admission (Peris, et al., 2011).  The nature of ICU admission 
criteria and subsequent therapies place patients at risk for stressors, including but not limited to, 
respiratory insufficiency, discomfort of tube insertions and labs draws, activation of the 
inflammatory cascade which includes brain inflammation and potential delirium with psychotic 
experiences relating to a lack of appropriate day-night cycling (Davydown et al., 2009).     
 With approximately 20% of adults experiencing a mental illness prior to admission to an 
ICU, a lack of appropriate medication reconciliation can truly create harm and risks for patient 
safety (APA, 2018).  Patients admitted to the ICU are already extremely physically ill and abruptly 
discontinuing prescribed psychiatric medications can lead to changes in sleep, increased anxiety, 
difficulty with emotions, sadness or tearfulness, fatigue, memory or concentration problems, flu-
like physical symptoms and diarrhea or constipation (Ostrow, Jessell, Hurd, Darrow & Cohen, 
2017).  Along with the physical symptoms, abruptly stopping psychiatric medications can lead to 
a reemergence of mental illness symptomatology, possibly create or increase existing suicidal 
ideations as well as explosive outburst and psychosis which may results in an increased length of 
stay (Ostro et al., 2017).   Lastly, stopping psychiatric medications can precipitate a loss of control 
resulting in a setback in treatment regimens for patients with a mental illness, increasing the loss 
of autonomy typically associated with an ICU admission.  In order to obtain the correct treatment 
regimen, patients with a mental illness may be forced to tolerate suffering and symptoms from four 
to six weeks before obtaining an effective medication state (National Institute of Mental Health 
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(NIMH), 2016).  Patients admitted to the ICU are at high risk for poor physical recovery without 
the added consequences associated with complications resulting from the lack of medication 
reconciliation.  
Agency Description 
Setting 
 This DNP project was implemented at an Intensive Care Unit (ICU) of a hospital in a large 
healthcare system located in a metropolitan area in the southeast United States.  The ICU in the 
study setting consists of 36 beds on two units of the acute-care setting.  These combined ICU units 
serve approximately 250 patients monthly; the majority have neurologic/neurosurgical, cardiac, 
pulmonary, medical, surgical and renal critical care needs.  In addition, many have several 
comorbid medical illnesses in addition to a psychiatric diagnosis.  
Target Population  
 The target population for the study was patients admitted to the ICU with a service level 
of intensive and who had both psychiatric and medical diagnoses.  The study period was July 1, 
2018 to December 31, 2018 during which time, 230 medical records met criteria for study inclusion 
out of the total 405 patients admitted to the ICU.  Using a random number generator, a random 
sample of 100 medical records was selected from the 230 eligible records.  
 Inclusion criteria for the study from the medical records of patients were: a) 18 years of 
age or older, b) admitted with a service level designation of intensive to the ICU, c) admitted 
between July 1, 2018 and December 31, 2018, and d) a documented past or current psychiatric 
diagnosis.   Exclusion criteria were: a) admitted or discharged with a legal status of incarceration.      
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Congruence of DNP Project and Norton Healthcare 
 The mission of the healthcare organization and hospital of the study site is to provide 
quality health care to all those in need, in a manner which responds to the needs of the community 
and honors the faith heritage.  This mission is achieved through vision and values statements about 
being the most comprehensive, strongest health care organization who sets the standard of quality 
care in the region and demonstrating stewardship of resources.  This study, which examines the 
demographic, clinical and treatment characteristics of patients with a psychiatric diagnosis in the 
ICU, contributed to the organization’s mission, since assessing the appropriate standard of care 
and resources for patients with a psychiatric diagnosis could result in improved patient care and 
safety.    
Description of Stakeholders 
 The stakeholders of this study included: the chief executive officers (CEOs), chief nursing 
officers (CNOs) and chief financial officers (CFOs); hospitalist providers; intensivist providers; 
registered nurses and patients with mental illnesses.   The CEOs, CNOs and CFOs are in charge 
of the day to day operations of the hospitals, assuring the quality of care and financial stewardship.  
The hospitalist and intensivist providers are on the front line of patient care, responsible for the 
reconciliation of patient medications and ultimately responsible for increased length of stays with 
subsequent cost.  The hospital and intensivist providers along with hospital nurses will also be 
directly impacted by the implications and practice change suggestions which emerge from this 
study.  Lastly, patients who are diagnosed with a mental illness are the key stakeholders as they 
will benefit from determining if collaborative care is being performed at the hospital ICU and any 
practice change implications.  
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Site-specific Facilitators and Barriers to Implementation 
 Multiple facilitators within the organization and hospital helped in the process of 
implementing this study.  The chief nursing officer, ICU director and ICU manager approved and 
supported the study.  The Director of Patient Care Services and the organization’s data analytics 
team was helpful in extracting critical data points from the medical records for review. An 
important barrier identified in the study was the subjective nature of the documentation of mental 
health diagnosis within the electronic medical record system.  In addition, there are a limited 
number of psychiatric providers within the healthcare system and therefore the majority of 
documented preexisting, mental illnesses were self, patient reported.    
Project Design 
 This study was based on a descriptive design with a retrospective medical record review to 
extract data on 100 randomly selected medical records of patients admitted to the ICU between 
July 1, 2018 and December 31, 2018 with both medical and psychiatric diagnoses.  The data 
extracted included the patients’ demographic, clinical and treatment characteristics, including the 
admission diagnosis, co-existing medical diagnosis, psychiatric diagnosis, frequency of 
psychiatric medication reconciliation, the use of recommended treatment modalities, patterns of 
service use and disposition upon discharge.    
Project Methods 
Procedure 
 A university medical Institutional Review Board (IRB) and the healthcare organization’s 
research office approved the study.  Secondary to the retrospective nature of the study, a waiver of 
documentation of informed consent was obtained as part of the approved IRB application.  
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Following study approval, data analytics staff compiled a list of potential medical records meeting 
the study inclusion criteria.  The Principal Investigator (PI) then reviewed each medical record for 
inclusion and exclusion criteria.  Once a list of eligible medical records was compiled, a sample of 
100 medical records was selected using a random number generator.  Each selected medical record 
was then assigned a unique identification number known only to the PI.  The PI then reviewed 
each of the selected medical records to obtain information related to the variables listed in Table 
1.  This information was recorded on a paper data collection tool (Appendix A). The data were 
then entered into an Excel spreadsheet and coded for use in SPSS.  Due to the span of the data 
points within the admission and co-existing medical diagnosis, type of psychiatric medication, 
sitter use, time surrounding psychiatric consults, race/ethnicity and marital status, some original 
categories were narrowed to facilitate interpretation of analysis.  
Measures and Instruments  
The following measures were extracted from the electronic medical records (Table 1): 
1. Diagnoses:  The diagnoses recorded included the admission diagnoses (neurological, 
cardiac/pulmonary and other), co-existing medical diagnoses (neurological, 
cardiac/pulmonary and other) and psychiatric diagnoses (schizophrenia, bipolar disorder, 
depression, anxiety, post-traumatic stress disorder and intellectual disability).  The 
diagnoses data were examined using frequencies and percentages.  
2. Medication Reconciliation: The medication reconciliation reviews were used to 
determine if the patients were on psychiatric medications prior to admission and, if so what 
type the patients were taking (antipsychotic, antidepressant/ mood stabilizer and/or 
anxiolytic), in addition to whether or not the medications were given to the patients during 
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admission.  The medication reconciliation data were examined using frequencies and 
percentages.  
3. Restraint use: Patient history of restraint use and type of restraints (medical or behavioral) 
during the hospital stay were collected.  The restraint use was compared to the prior to 
admission psychiatric medications using chi-square analysis and the type of restraints used 
were examined with frequencies and percentages.  
4. Sitter use: Patient history of sitter use during the hospital stay was explored.  The 
proportion of patients who were on a prior to admission psychiatric medication and had a 
sitter ordered were examined using chi-square analysis.   
5. As needed medications: The use of as needed or PRN medications with the indication for 
use listed as anxiety or agitation was recorded.  The proportion of patients who were on a 
prior to admission psychiatric medication and had an as needed medication ordered were 
examined using chi-square analysis.   
6. Psychiatric consult: Orders were reviewed for psychiatric providers consults during the 
hospital stay along with the time between admission and when the order was placed, as 
well as the duration between when the order was placed and the psychiatric provider 
completed the consult.  The proportion of patients who were on a prior to admission 
psychiatric medication and had a psychiatric consult ordered were examined using chi-
square analysis.   
7. Length of stay: Total number of hours patients were admitted to the ICU and the overall 
hospital stay were collected.  The length of stay data were examined proportionately to the 
four prior to admission psychiatric medication groups using Mann-Whitney U analyses and 
interquartile ranges.  
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8. Discharge disposition: The location of the patients upon discharge from the hospital 
(home, rehab or deceased) were recorded.  Chi-square analyses were used to examine the 
differences between the four medication groups and the discharge disposition.  
9. Demographics: The demographic data included gender (male vs. female), age (in years), 
race (white, black, or Hispanic) and marital status (partnered or non-partnered) were 
collected.  The demographic data were examined using frequencies and percentages and 
means and standard deviations.    
Results 
Sample Characteristics (Table 2 & 3) 
 The sample (N=100) was primarily female (60%), white (90%), non-partnered (55%) and 
on average 54.02 (SD= 15.01) years of age.  An overwhelming majority of the sample had a 
primary admission diagnosis of a neurological condition (63%), followed by other diagnosis (22%) 
and finally cardiac/pulmonary diagnosis (15%).  The sample suffered from a significant percentage 
of co-existing medical diagnoses including cardiac/pulmonary (83%) and other (83%) followed 
by neurological (53%).  The nonexclusive, primary psychiatric diagnosis was anxiety (75%), 
followed by depression (63%).  Nearly three quarters of the sample was on a psychiatric 
medication prior to admission (71%) including antidepressants/mood stabilizers (56%), followed 
by anxiolytics (33%) and antipsychotics (16%).   
Differences in Prior to Admission Psychiatric Medication Reconciliation Completion 
 As illustrated in Table 4, of the 71% of the sample that was on a psychiatric medication 
prior to admission, antipsychotic medications (68.8%) and antidepressant/mood stabilizers 
(76.8%) were restarted within 23 hours of admission at a significantly higher frequency when 
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compared to anxiolytic medications (39.4%).  Of the sample whose medications were not started 
prior to 23 hours from admission, all three medication groups (20.0%, 38.5% and 15.0%) had a 
relatively low frequency of having a prior to admission psychiatric medication started between 24 
hours and discharge.  On the contrary, greater than 70% of the sample had prior to admission 
psychiatric medications restarted or continued at discharge.  While those in the sample on 
anxiolytic medications had the lowest continuation of medication at less than 23 hours from 
admission, the frequency of anxiolytic medications restarted at discharge nearly doubled (39.4% 
vs. 72.7%).  In addition, of the portion of the sample on antipsychotic medications (N=16), almost 
one-third of this group (68.6% vs. 93.8%) was abruptly taken off the antipsychotic medication on 
admission and then restarted on the medication upon discharge (see Table 4).  
Treatment Modalities and Patterns of Service Use differences between those with and 
without prior to Admission Psychiatric Medications.   
  Table 5 presents the differences in admission diagnosis, co-existing medical diagnoses, 
restraint use, PRN medication use, psychiatric consults and disposition upon discharge between 
the sample with and without a prior to admission psychiatric medication, along with differences 
between the three psychiatric medication classifications.  Neurological admitting diagnoses 
(68.8%, 71.4%, 66.7% and 48.3%) surpassed cardiac/pulmonary and other diagnoses in all 
medication classifications, yet had the lowest percentage among the sample who were not on a 
prior to admission psychiatric medication.  There were no significant trends among co-existing 
medical diagnoses in the different medical classifications.  Restraint use overall was relatively low, 
less than 40%, in the study sample across all medication classifications.  Documentation of 
psychiatric consult orders was also proportionately low across the entire sample population, with 
the highest percentage being among those on an antipsychotic medication (25%).  Overall, among 
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all medication classifications, the majority of the sample were discharged home followed by 
rehabilitation.    
 While all of the above data showed trends among some of the medication classifications, 
the only significant data involved PRN medication use among those who were on an anxiolytic 
medication prior to admission.  Of the sample who were on an anxiolytic prior to admission, both 
the percentage of those who used a PRN medication (yes) and those who did not (no) was 
statistically significant (45.5% and 54.5% respectively).   
ICU and Hospital Length of Stay (LOS) difference between those with and without prior to 
Admission Psychiatric Medications 
 Table 6 presents the differences between ICU and hospital length of stays (LOS) when 
compared to the four medication classifications.  The ICU LOS of all four medication 
classifications varied minimally within a few hours of one another.  However, when compared to 
those taking an antidepressant/mood stabilizer prior to admission, those taking an antipsychotic or 
anxiolytic prior to admission had an overall longer median hospital LOS (59.0 hours vs. 90.0 
hours).  Overall, there were no significant differences in the ICU or hospital LOS in regards to the 
medication classifications.  
Discussion  
 This study examined the demographic and clinical characteristics of patients with both 
medical and psychiatric diagnoses admitted to an ICU, as well as the impact of prior to admission 
psychiatric medications on treatment characteristics.  Based on literature searches (CINAHL, 
Healthsource, MEDLINE and Proquest) studies of this type have not been reported and to my 
knowledge, this is the first study to make comparisons between the type of psychiatric medications 
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a patient is taking and the ICU treatment characteristics.  The main finding of this study was the 
significantly higher percentage of the sample who suffered from a prior to admission psychiatric 
diagnoses in comparison to the national average.  In the United States, an average of 20% of 
Americans suffering from a psychiatric illness yearly (APA, 2018).  In this study, history of 
psychiatric illnesses was largely self-reported; however, of the 405 patients admitted during the 
study period 230 (56.8%) had a psychiatric diagnosis.  Although this study finding cannot be 
generalized, given the random sample determined for analysis, it is reasonable to question whether 
or not half of all patients admitted to the ICU at the study hospital would have a psychiatric 
diagnosis prior to admission requiring the attention of the hospital personnel.   
 In addition to the high percentage of the study sample having a psychiatric diagnosis, 
medical records indicated that 75% had anxiety, 63% had depression and 71% were on a 
psychiatric medication prior to admission.  These percentages are higher than national estimates, 
thus re-affirming the profound prevalence of psychiatric conditions within the sample population.  
However, despite the high prevalence rates found in this study, it does not account for additional 
portions of the population which may develop anxiety, depression or PTSD as a result of the ICU 
stay.  With advances in medicine, patients are surviving critical illnesses which in the past were 
not survivable (Rattray & Hull, 2008).  Along with this increasing survival rate, there is a high 
likelihood that there will be increases in significant emotional and psychological problems 
secondary to isolation, discomfort of tube insertions, sleep deprivation, physical confinement, 
time-spacial disorientation, sensory overstimulation, depersonalization and loss of autonomy 
(Davydow et al., 2009; Peris et al., 2011).  In addition, with greater than 50% of the sample having 
a preexisting psychiatric diagnosis as well as the potential for intra-intensive care unit psychiatric 
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complications, the need is crucial for early recognition and intervention of psychiatric symptoms 
among hospital ICU patient populations.  
 The second major finding of this study was the lack of correct medication reconciliation of 
psychiatric medications.  Although not statistically significant, a noteworthy amount of the sample 
had the psychiatric medications abruptly stopped or held for a number of days.  Findings revealed 
that 8 out of 56 patients on antidepressant/mood stabilizers were restarted on their psychiatric 
medications during their hospital stay, compared to those on antipsychotics (4 out of 16) or 
anxiolytics (17 out of 33).  Again while neither statistically significant nor generalizable, the 
statistics in the sample indicated that 4 patients had abrupt interruptions in antipsychotic 
medication prescriptions and 17 patients had abrupt interruptions in anxiolytic medication 
prescriptions.  While provider reasoning for stopping the medications were frequently not listed, 
patients who have abrupt interruption in medications are subject to significant side effects or 
withdrawal symptoms that may include nausea, vomiting, diarrhea, trouble sleeping, anxiety or 
agitation which can compound the medical diagnoses and increase intra-intensive care unit 
psychiatric complications. 
 The final major finding of this study was the high proportion (63%) of the sample with a 
neurological admitting diagnosis.  Even though the site of the study includes a comprehensive 
stroke center accepting stroke patients from a wide geographical region, the high percentage 
findings were not expected secondary to the ICU being a medical-surgical ICU.  The neurological 
diagnoses ranged from hemorrhagic or ischemic stroke to brain tumors and patients with 
uncontrolled seizures.  All of these neurological diagnoses place the study population at an 
increased risk for psychiatric diagnosis, especially depression, anxiety or adjustment disorders.  
For instance, Hacket and colleagues (2012) reported that approximately one-third of all patients 
22 
 
who have experienced a stroke will suffer from post-stroke depression within the first year.  In 
addition, Arnold et al. (2009) found that almost half of all patients with brain tumors suffer from 
depression.  Abrupt interruptions of medication management can also have an effect on the central 
nervous system.  For example, the combination of the physiological stress response may result in 
activation of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system.  
Therefore, a sudden change in neurotransmitter functioning that is likely to result from 
discontinuation of psychiatric medications could lead to significant physical and psychiatric 
complications for patients.  While the physiological stress from a stroke may not be mediated, 
accurate medication reconciliation of psychiatric medications in ICU patients by providers can 
potentially limit problems resulting from changes in the physiologic functioning of 
neurotransmitters.  
 Overall the major findings of this DNP study were the increased rate of prior to admission 
psychiatric diagnoses, the lack of appropriate medication reconciliation of psychiatric medications 
and the abundance of neurological patients within the sample.  These findings support the necessity 
for: thorough assessments by healthcare providers to assure awareness of the patient psychiatric 
diagnosis; focused education regarding psychiatric diagnoses emphasizing collaborative care, and 
treatment emphasizing appropriate reconciliation of psychiatric medications for patients in ICU.  
Limitations 
 A few limitations should be considered when interpreting the findings of this study.  First, 
there was a limitation in that the majority of the prior to admission psychiatric diagnoses found in 
the medical records were patient reported versus physician reported.  For instance, because the 
majority of the psychiatric diagnoses were reported by the patients, the information was listed in 
the past medical history section of the chart instead of the problem list which is provider designated 
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with associated diagnostic codes.  Therefore, the reporting method led to difficulty when 
identifying patients who meet the inclusion criteria; this limitation may have also contributed to 
the finding related to increased rates of prior to admission psychiatric diagnoses in comparison to 
national averages.  
 Secondly, the study data regarding medication reconciliation of psychiatric medications 
may not show whether the complete process of medication reconciliation was completed.  
Medication reconciliation requires the admitting nurse or provider to review the medication list 
with the patient, family members or patient pharmacy to verify correct medications and dosages.  
Because of EMR computer charting, it was not possible to explore whether the prior to admission 
medications were actually reviewed with the patient on admission or simply carried over from a 
prior visit.  Nor could it be determined if medications were linked to a diagnostic code, thus 
limiting the ability to see if, for example, an antipsychotic medication was being used as an adjunct 
treatment for resistant depression or true psychotic symptoms.   
 Third, the increased rate of neurological admitting diagnoses (63%) may have influenced 
the rates of prior to admission psychiatric diagnoses.  Patients with stroke, brain tumors and 
uncontrolled seizures have a high incidence of depression and anxiety (Hacket et al., 2012; Arnold 
et al., 2009).  However, this is consistent with the study setting of a comprehensive stroke center 
and it contributes to the importance of addressing study implications. 
 Lastly, with the exploratory descriptive nature of these study the data is not generalizable 
outside the current healthcare system.  However, this study’s data has confirmed prior observations 
and has value and utility in guiding changes in practices within the healthcare system to improve 
patient outcomes. 
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Implications for Future Doctoral Nursing Practice and Research 
Psychiatric Diagnoses, Treatment Modalities and Patterns of Service Use 
 One recommendation regarding the prior to admission psychiatric diagnoses would be to 
expand the study time period and sample size, to assure that the increased rate of prior to admission 
psychiatric diagnoses is significant.  If this is the case, the argument could be made to investigate 
the study facility in comparison to other facilities within the system to determine if there are more 
extensive trends between the admitting diagnosis and prior to admission psychiatric diagnosis.  
Additionally, with an extended study time period and sample comparison of demographics, an 
examination of treatment modalities and patterns of service use could be conducted between 
patients who have a prior to admission psychiatric diagnosis and those who do not.  This might 
increase the chance of a more clear statistical comparison to determine if the prior to admission 
psychiatric diagnosis makes a statistical difference in the rate of restraint use, psychiatric consults, 
PRN medication use and length of stays.  
 A second recommendation regarding prior to admission psychiatric diagnosis, which 
would help clarify diagnoses within the medical records, would be to implement collaborative care 
within the healthcare system.  The current care model within the study site deals with medical and 
psychiatric illnesses separately.  Psychiatric illnesses are handled and a psychiatric consult placed 
only when the psychiatric illnesses supersedes the medical illness or becomes a major 
complication.  This is supported by the minimal use (less than 25.0%) of psychiatric consults 
during the study period.  Instituting the Collaborative Care Model developed by the American 
Psychiatric Association (APA) and the Academy of Psychosomatic Medicine (APM) across the 
healthcare system would operationalize psychiatric care from the primary care practice all the way 
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up through inpatient hospital stays.  This would improve access to evidence-based mental health 
care across the entire healthcare system (APA, 2016).     
Medication Reconciliation 
 The recommendation for evidence-based nursing practice surrounding medication 
reconciliation would be to explore the current process.  Currently, the study site’s institutional 
policy is for the physician, physician’s assistant, nurse practitioner or registered nurse to make a 
good faith effort to verify the patient’s home medications with the listing in the electronic medical 
record from the patient, family members and/or significant others.  However, problems may occur 
if patients are unsure of their medication list or unable to communicate with providers.  In addition, 
the admitting provider may continue medications based on an expired list.  Finally, not all of the 
patient’s providers are linked through the same electronic medical record system.  Further research 
is required to address limitations and barriers to correct medication reconciliation along with 
potential processes such as contacting patient pharmacies for current prescriptions or having the 
reconciliation process completed by pharmacist.   
Implications using DNP Essentials 
 In order to further examine the association of the demographic, clinical and treatment 
characteristics of patients with both medical and psychiatric diagnosis admitted to an Intensive 
Care Unit (ICU), a Doctoral Nursing Practice (DNP) graduate can be guided by principles evident 
in the domains of several of the DNP Essentials.  They include:  Essential II, Organizational and 
System Leadership for Quality Improvement; Essential III, Clinical Scholarship; Essential IV, 
Information Systems/Technology; Essential VI, Interprofessional Collaboration; and Essential 
VIII Advanced Nursing Practice (AACN, 2006).   
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 DNP graduates are also prepared to conceptualize new care delivery models which are 
focused on the target population of patients in order to impact policies and procedures to meet the 
overall health needs of this population (AACN, 2006).  Examples include investigating barriers at 
the system level that may need to be changed to help medical providers acknowledge psychiatric 
diagnoses; in addition, elimination of barriers can facilitate correct medication reconciliation 
among advanced practice registered nurses (APRNs), depending upon the practitioner’s specialty.  
Specific scholarship efforts include additional retrospective chart reviews or a qualitative study to 
investigate the providers’ and staffs’ opinions about psychiatric diagnoses to uncover undue biases.  
 DNP Essential III states that the DNP graduate is capable of using analytic methods to: 
critically appraise existing literature; identify and compare variability between practice settings 
and national benchmarks; and determine and implement the best evidence for practice (AACN, 
2006).  It is important to build on the findings of this study to identify other areas for additional 
research as well as foster study by other DNP graduate who are prepared to appraise the literature 
for connections.  Most important, it is essential for all providers including DNP graduates to apply 
this knowledge to solve the problems regarding patients with psychiatric conditions in general and 
those admitted to the ICU.  These efforts will enable the DNP graduate’s use of the combination 
of essentials III and VI to lead the implementation of evidence-based, collaborative care.  
 The DNP graduate has advanced preparation in leading interprofessional collaboration and 
overcoming hindrances to interprofessional practice; these skills can create highly fluid 
collaborative teams (AACN, 2006).  With foundational knowledge and evidence-based research, 
the DNP graduate will be able to practice at the full scope of their APRN license and apply the 
broad range of competencies of the DNP role, for the purpose of leading the development of 
collaborative care models within the inpatient setting and between the inpatient and outpatient 
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settings.  They will also be prepared to develop implementation strategies to educate inpatient 
providers in order to institute the collaborative care models.   
 Finally, within the context of APRN licensure, the DNP graduate will be able to apply 
Essentials IV and VIII, to improve the overall medical reconciliation process, thus assuring that 
patients’ medication regimens are continued rather than interrupted during inpatient treatment.  
This too is an important area for additional research in order to better understand and eliminate the 
barriers and limitations of medication reconciliation on a system level as well as assess the efficacy 
of the current policies and procedures (AACN, 2006).  Finally, DNP graduates will contribute to 
optimal quality of care and patient safety through the implementation of new, evidence-based 
interventions and development of policies and procedures to increase the accuracy of medication 
reconciliations.  In addition, through the collaborative care model, the DNP can work to 
incorporate the recommendations of Murphy et al. (2009) in working to have a pharmacist 
complete the medication reconciliation or having staff contact the patient’s outside pharmacy in 
order to obtain a current prescription list.   
Conclusion 
 Approximately 20% of all adults in the United States will experience a mental illness 
(APA, 2018).  Furthermore, more than 40% of all individuals in the United States have a chronic 
physical illness.  Still others have a co-existing mental and physical health condition and these 
patients tend to have even higher rates of chronic health conditions that are often secondary to the 
side effects of psychotropic treatments, disparities in health care access and utilization of services 
(CDC, 2012 & De Hert et al., 2011).  There remains limited research concerning collaborative care 
in the inpatient healthcare setting.  However, the preliminary findings of this DNP project suggest 
the need for more exploratory research that can guide practice and policies to enhance care for 
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patients with psychiatric and medical comorbidities in the ICU setting.   In conclusion, additional 
research is needed to determine the needs of patients with co-existing conditions in acute care and 
ICU settings as well as comparisons of a collaborative care model with those currently in place.    
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Table 1. Measures 
Variable name Measures Data Source Level of measure Statistical 
analysis 
Aim 1 
Admission 
Diagnosis 
 
 
Co-existing 
Medical 
Diagnosis 
 
 
Psychiatric 
diagnosis 
Neurologic 
Cardiac/Pulmonary 
Other 
 
Neurologic 
Cardiac/Pulmonary 
Other  
 
Schizophrenia 
Bipolar Disorder 
Depression 
Anxiety 
PTSD 
Intellectual Disability 
EMR 
 
 
 
EMR  
 
 
 
EMR 
Nominal 
 
 
 
Nominal 
 
 
 
Nominal 
Frequencies and 
Percentages 
 
 
Frequencies and 
Percentages 
 
 
 
Frequencies and 
Percentages 
 
 
Aim 2 
Taking psych 
meds prior to 
admission 
Classification of 
Psych med 
Yes or No 
 
Antipsychotic         
Antidepressant/ 
Mood Stabilizer 
Anxiolytic 
EMR 
 
EMR 
Nominal 
 
Nominal 
Frequencies and 
Percentages 
Frequencies and 
Percentages 
Psych medication 
reconciliation 
status 
Antipsychotics 
- Continued in 
less than 23 hours 
from admission 
(May not be mutually 
exclusive) 
 
 
Yes or No 
 
 
 
 
 
EMR 
 
 
 
 
 
Nominal  
 
 
 
 
 
Frequencies and 
Percentages 
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- Restarted 
between 24 hours 
and discharge 
- Restarted at 
discharge only 
 
Antidepressant/M
ood Stabilizer 
- Continued in 
less than 23 hours 
from admission 
- Restarted 
between 24 hours 
and discharge 
- Restarted at 
discharge only 
Anxiolytic 
- Continued in 
less than 23 hours 
from admission 
- Restarted 
between 24 hours 
and discharge 
- Restarted at 
discharge only 
Yes or No 
 
Yes or No 
 
 
 
Yes or No 
 
 
Yes or No 
 
Yes or No 
 
 
Yes or No 
 
Yes or No 
 
Yes or No 
EMR 
 
EMR 
 
 
 
EMR 
 
 
EMR 
 
EMR 
 
 
EMR 
 
EMR 
 
EMR 
Nominal 
 
Nominal 
 
 
 
Nominal 
 
 
Nominal 
 
Nominal 
 
 
Nominal 
 
Nominal 
 
Nominal 
Frequencies and 
Percentages 
Frequencies and 
Percentages 
 
 
 
Frequencies and 
Percentages 
 
Frequencies and 
Percentages 
 
Frequencies and 
Percentages 
 
Frequencies and 
Percentages 
Frequencies and 
Percentages 
Frequencies and 
Percentages 
Aim 3 
Restraints  
- ordered 
-Type (Medical or 
Behavioral) 
 
Yes or No 
Yes or No 
 
EMR 
EMR 
 
Nominal 
Nominal 
 
Chi-square 
Frequencies and 
Percentages 
- Sitter ordered Yes or No EMR Nominal Chi-square 
PRN medication 
given for anxiety 
or agitation 
Yes or No EMR Nominal Chi-square 
Psychiatric 
Consult  
- Ordered 
 
 
Yes or No 
 
 
EMR 
 
 
Nominal 
 
 
Chi-square 
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- hours from 
admission to 
ordered 
- hours from order 
placed to 
completed 
# of hours 
 
# of hours 
EMR 
 
EMR 
Nominal 
 
Nominal 
Frequencies and 
Percentages 
Frequencies and 
Percentages 
Length of Stay in 
hospital 
Length of Stay in 
ICU 
# of hours 
 
# of hours 
EMR 
 
EMR 
Ratio 
 
Ratio 
Mann-Whitney U 
and interquartile 
ranges 
Mann-Whitney U 
and interquartile 
ranges 
Disposition on 
discharge 
Home 
Rehab 
Deceased 
EMR Nominal  Frequencies and 
Percentages 
Demographics 
Age Age of participant in 
years 
EMR Nominal Mean with 
standard deviation 
Gender Male, female EMR Nominal Frequency 
Race White, Black, 
Hispanic 
EMR Nominal Frequency 
Marital Status Partnered, Non-
partnered 
EMR Nominal Frequency 
 
Table 2. Demographic characteristics of patients admitted to the ICU with a psychiatric diagnosis 
(N=100) 
 Mean (SD) or n (%) 
Age 54.02 (15.01) 
Gender 
   Male 
   Female 
 
40 (40%) 
60 (60%) 
Race/ethnicity 
   White 
   Black 
   Hispanic 
 
90 (90%) 
9 (9%) 
1 (1%) 
Marital Status 
   Partnered 
   Non-partnered 
 
45 (45%) 
55 (55%) 
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Table 3. Clinical characteristics of patients admitted to the ICU with a psychiatric diagnosis 
(N=100) 
 n (%) 
Admission Diagnosis 
   Neurological 
   Cardiac/pulmonary 
   Other 
 
63 (63%) 
15 (15%) 
22 (22%) 
Co-existing Medical Diagnosis a 
   Neurological  
   Cardiac/pulmonary 
   Other 
 
53 (53%) 
83 (83%) 
83 (83%) 
Psychiatric Diagnosis a 
   Schizophrenia 
   Bipolar Disorder 
   Depression 
   Anxiety 
   PTSD 
   Intellectual Disability 
 
3 (3%) 
9 (9%) 
63 (63%) 
75 (75%) 
4 (4%) 
3 (3%) 
Prescribed Psychiatric Medications Prior 
to Admit 
   Yes 
   No 
 
Types of Psychiatric Medicationsa (N=71) 
   Antipsychotic 
   Antidepressant/Mood Stabilizer 
   Anxiolytic 
 
 
71 (71%) 
29 (29%) 
 
 
16 (16%) 
56 (56%) 
33 (33%) 
  
apatients may have more than one diagnosis, medication, etc. 
Table 4. Medication Reconciliation of Prior to Admission Psychiatric Medications (N= 71)  
Medication grouping Medication restarted 
within 23 hours 
n (%) 
Medication restarted 
between 24 hours and 
discharge 
n (%) 
Medication restarted 
at discharge  
n (%) 
Antipsychotic 
(N=16) 
   Yes 
   No 
 
 
11 (68.8%) 
5 (31.3%) 
 
 
1 (20.0%) 
4 (80.0%) 
 
 
15 (93.8%) 
1 (6.3%) 
Antidepressant/ 
Mood Stabilizer 
(N=56) 
   Yes 
   No 
 
 
 
43 (76.8%) 
13 (23.2%) 
 
 
 
5 (38.5%) 
8 (61.5%) 
 
 
 
49 (87.5%) 
7 (12.5%) 
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Anxiolytic  (N=33) 
   Yes 
   No 
 
13 (39.4%) 
20 (60.6%) 
 
3 (15.0%) 
17 (85.0%) 
 
24 (72.7%) 
9 (27.3%) 
a patients may be on more than one medication 
 
Table 5. Treatment Modalities and Patterns of Service Use in Accordance with Prior to 
Admission Psychiatric Medications.   
  Antipsychotica 
(N=16) 
Antidepressant/Mooda 
Stabilizer (N=56) 
Anxiolytica 
(N=33) 
 
No prior 
psych 
medications 
(N=29) 
Admission 
Diagnosis 
    Neurological 
    Cardiac/pulmonary 
    Other 
 
 
68.8% 
18.8% 
12.5% 
 
 
71.4% 
10.7% 
17.9% 
 
 
66.7% 
9.1% 
24.2% 
 
 
48.3% 
20.7% 
31.0% 
Co-existing Medical 
Diagnosisa (% yes) 
    Neurological  
    Cardiac/pulmonary 
    Other 
 
 
56.3% 
75.0% 
81.3% 
 
 
55.4% 
85.7% 
83.9% 
 
 
57.6% 
87.9% 
81.8% 
 
 
41.4% 
79.3% 
82.8% 
Restraint use (%) 
    Yes 
    No 
 
12.5% 
87.5% 
 
28.6% 
71.4% 
 
36.4% 
63.6% 
 
20.7% 
79.3% 
PRN medication 
used (%) 
    Yes 
    No 
 
 
18.8% 
81.3% 
 
 
25.0% 
75.0% 
 
 
45.5% 
54.5% 
 
 
24.1% 
75.9% 
Psych consult 
placed (%) 
    Yes 
    No 
 
 
25.0% 
75.0% 
 
 
7.1% 
92.9% 
 
 
15.2% 
84.8% 
 
 
10.3% 
89.7% 
Disposition upon 
discharge from 
hospital 
    Home 
    Rehab 
   Hospice/Deceased 
 
 
 
75.0% 
25.0% 
0.0% 
 
 
 
 
64.3% 
26.8% 
8.9% 
 
 
 
57.6% 
30.3% 
12.1% 
 
 
 
82.8% 
6.9% 
10.3% 
a patients may be on more than one medication or co-existing medical diagnosis 
(Significant comparisons in bold) 
 
38 
 
Table 6. Length of Stay (hours) outcomes by Type of Prior to Admission Psychiatric 
Medications 
 ICU LOS 
Median (IQR) 
p- value Hospital LOS 
Median (IQR) 
p-value 
Antipsychotica 
(N=16) 
   Yes 
   No 
 
 
39.0 (23.0-95.0) 
45.0 (23.5-94.0) 
 
0.768 
 
 
90.0 (39.0-170.0) 
62.0 (35.0-180.5) 
 
0.566 
Antidepressant/ 
Mood Stabilizera 
(N=56) 
   Yes 
   No 
 
 
46.5 (23.5-91.5) 
42.0 (23.25-121.0) 
 
0.892 
 
 
59.0 (39.5-163.5)  
75.0 (34.0-184.0) 
 
0.624 
Anxiolytica  
(N=33) 
   Yes 
   No 
 
 
45.0 (22.0-92.0) 
44.0 (25.0-99.0) 
 
0.895 
 
 
90.0 (34.5-189.0) 
62.0 (36.0-141.0) 
 
0.545 
No prior psych 
medications 
(N=29) 
    Yes 
    No 
 
 
 
47.0 (22.5-168.0) 
41.0 (23.0-90.0) 
 
0.250 
 
 
 
72.0 (35.0-203.0) 
61.0 (35.0-170.0) 
 
0.713 
a patients may be on more than one medication 
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Appendix A: Data Collection Form 
Comorbid Mental and Physical Health Conditions in an ICU setting 
Nicole Ryan, RN, BSN, Primary Investigator 
UK-IRB approved study 46928 
1. Unique study number:                        ___________ 
2. Age:                                                    ____ 
3. Gender:                                               ____ Male   ____ Female  ____ Other 
4. Race:     _____ American Indian or Alaska Native 
     _____ Asian 
     _____ Black or African American 
     _____ Hispanic or Latino 
     _____ Native Hawaiian or Other Pacific Islander  
     _____ Other 
     _____ White or Caucasian 
 
5. Marital status:                          _____ Divorced 
      _____ Legally Separated 
      _____ Married 
      _____ Other 
      _____ Significant Other 
      _____ Single 
      _____ Unknown 
      _____ Widowed 
 
6. Admission Diagnosis:    _____ Neuro 
     _____ Respiratory 
     _____ Cardiovascular 
     _____ Gastrointestinal 
     _____ Genitourinary 
     _____ Endocrine 
     _____ Malignancy 
     _____ Infectious Disease 
     _____ Musculoskeletal 
     _____ EENT 
     _____ Integumentary 
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7. Other Medical Diagnosis:   _____ Neuro 
     _____ Respiratory 
     _____ Cardiovascular 
     _____ Gastrointestinal 
     _____ Genitourinary 
     _____ Endocrine 
     _____ Malignancy 
     _____ Infectious Disease 
     _____ Musculoskeletal 
     _____ EENT 
     _____ Integumentary 
 
8. Psychiatric Diagnosis:  _____ Schizophrenia 
     _____ Bipolar Disorder 
     _____ Depression 
     _____ Anxiety 
     _____ PTSD 
     _____ Intellectual Disability 
 
9. Psychiatric Medication Prior to Admission:   _____ Yes 
      _____ No 
10. Type of Psychiatric Medication:  ____ Antipsychotic 
       _____ Antidepressant 
       _____ Mood Stabilizer 
       _____ Stimulant 
       _____ Anxiolytic 
11. Psychiatric Medication Continued in less than 23 hours: _____ Yes   _____ No 
    Which ones? __________________________ 
12. Psychiatric Medication Restarted between 24 hours and discharge: ____ Yes   ____ No  
    Which ones? __________________________ 
13. Psychiatric Medication Restarted at Discharge:      _____ Yes    _____ No 
14. Restraints Ordered:   _____ Yes    _____ No 
15. Type of restraints:    _____ Medical    _____ Behavioral 
16. Sitter ordered:    _____ Yes    _____ No 
17. PRN medication for anxiety or agitation:   _____ Yes    _____ No 
    Which ones? ___________________________ 
18. Psychiatry consult ordered:   _____ Yes    _____ No 
19. Hours from admission to psychiatric consult placed:    _____ hours 
20. Hours between psychiatric consult order placed to completed:    _____ hours 
21. ICU length of stay:  _____ days   _____ hours 
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22. Hospital length of stay:  _____ days    _____ hours 
23. Disposition on discharge:  _____ Home 
     _____ Acute rehab 
     _____ Subacute rehab 
     _____ Inpatient psych 
     _____ Nursing home 
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Appendix B: Data Coding Form 
Chart Audit Data Coding Form 
Patient Identification Code Numeric  
Age Numeric 
Gender Male-0, Female-1 
Race See Key 
Marital Status See Key 
Admission Diagnosis See Key 
Co-existing Diagnosis See Key 
Psychiatric Diagnosis See Key 
Psychiatric medication prior to admission Yes- 0, No- 1 
Type of psychiatric medication See Key 
Psychiatric medication continued less than 
23 hours 
Numeric 
Psychiatric medication restarted between 
24 hours and discharge 
Numeric 
Psychiatric medication restarted at 
discharge 
Numeric 
Restraints ordered Yes- 0, No- 1 
Type of restraints Medical- 0, Behavioral- 1 
Sitter Yes- 0, No- 1 
PRN medication for anxiety or agitation Yes- 0, No- 1 
Psychiatric Consult ordered  Yes-0, No-1 
Hours between admission and psychiatric 
consult place 
Numeric 
Hours between psychiatric consult ordered 
and completed 
Numeric 
ICU Length of stay in hours Numeric  
Hospital Length of stay in hours Numeric 
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Disposition on Discharge See key 
 
Key: 
Ethnicity       Psychiatric Medication 
Black or African American: 1   Antipsychotic: 1 
Hispanic or Latino: 2     Antidepressant/Mood Stabilizer: 2 
White or Caucasian: 3     Anxiolytic: 3 
Marital Status     Disposition on Discharge 
Partnered: 1      Home: 1 
Non-partnered: 2     Rehab: 2 
Admission Diagnosis     Hospice/deceased: 3  
Neurological: 1 
Cardiac/pulmonary: 2 
Other: 3 
Co-existing Diagnosis 
Neurological: 1 
Cardiac/pulmonary: 2 
Other: 3 
Psychiatric Diagnosis 
Schizophrenia: 1 
Bipolar: 2 
Depression: 3 
Anxiety: 4 
PTSD: 5 
Intellectual Disability: 6 
 
